Ctxr earnings date
WebApr 10, 2024 · The trading price of Citius Pharmaceuticals Inc. (NASDAQ:CTXR) closed higher on Thursday, April 06, closing at $1.37, 4.58% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.2809 and $1.40. In examining the 52-week pr WebMay 6, 2024 · Additional sites to support trial completion by end of 2024. CRANFORD, N.J. , May 6, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR ), a late-stage ...
Ctxr earnings date
Did you know?
WebFind real-time CTXR - Citius Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. ... Earnings growth (this year) +31.88%: ... Next reporting date: May 11, 2024 ... WebJul 14, 2024 · CTXR Citius Pharmaceuticals $1.28 / -0.015 (-1.16%) 12/01/22 ... Earnings. Fortress Biotech reports Q3 EPS ... Up-to-date information on important industry events Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
WebMar 29, 2024 · Citius Pharmaceuticals, Inc. (CTXR) latest earnings report: revenue, EPS, surprise, history, news and analysis. ... Earnings Date & History. Follow 6.83K followers … Web19 rows · Mar 24, 2024 · Earnings for Citius Pharmaceuticals are expected to grow in the coming year, from ($0.11) to ...
WebCitius Pharmaceuticals Inc (CTXR) Earnings Date. Citius Pharmaceuticals Inc has confirmed Earnings date and time. It is on Thu 11 May (In 51 Days). The Algorithm … WebView the real-time CTXR price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. ... CTXR Earnings-$0.06-$0.04-$0.02. $0.00. Q4 FY21. Q1 FY22. Q2 FY22. Q3 FY22.
WebFind the latest Earnings Report Date for Citius Pharmaceuticals, Inc. Common Stock (CTXR) at Nasdaq.com.
WebApr 2, 2024 · NASDAQ CTXR opened at $1.17 on Friday. The firm has a market cap of $171.12 million, a P/E ratio of -6.50 and a beta of 1.40. The stock’s 50-day moving average is $1.18 and its 200-day moving ... chrp onlineWebApr 6, 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Cemtrex stock is Buy based on the current 1 buy rating for CETX. The average twelve-month price prediction for Cemtrex is $23.00 with a high price target of $23.00 and a low price target of $23.00. Learn more on CETX's analyst rating history. dermika mesotherapist na nocWebApr 9, 2024 · When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Delta Air Lines' historic earnings and revenue below, but keep in mind there's always more to the story. NYSE:DAL Earnings and Revenue Growth April 9th 2024 dermifant prevent bad und shampoodermies cibinong city mallWebCitius Pharmaceuticals, Inc. (CTXR) Stock Price, News, Quote & History - Yahoo Finance My Portfolio Dow 30 +123.91(+0.37%) Nasdaq 12,025.57 -58.78(-0.49%) Russell 2000 … dermillume light helmetWebApr 10, 2024 · Citius Pharmaceuticals (CTXR) posted a 23Q1 loss of $0.02 per share, better than I had anticipated, mostly because of a $3.6 gain on the sale of net operating loss carryforwards (equivalent to $0.02 per share) from the State of New Jersey and also due to modestly lower-than-expected operating costs. dermika esthetic solutions opinieWebApr 4, 2024 · Key Expected Earnings Data Earnings Summary For their last quarter, Citius Pharmaceuticals (CTXR) reported earnings of -$0.04 per share. This reflects a … der mighty + medic